Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials

por Salliot, C, Dougados, M, Gossec, L
Publicado 2009

Factors associated with a bad functional prognosis in early inflammatory back pain: results from the DESIR cohort

por Lukas, C, Dougados, M, Combe, B
Publicado 2016

Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials

por Gaujoux-Viala, C, Dougados, M, Gossec, L
Publicado 2009

Clusterin, a potential pathophysiological actor in rheumatoid arthritis

por Devauchelle, V, Breban, M, Dougados, M, Fournier, C, Chiocchia, G
Publicado 2004

Linking genotype to cell function in chronic inflammation: analysis of the IL-23/Th17 axis in spondylarthropathy

por Roumier, M, Coffre, M, Law, H, Salliot, C, Dougados, M, Bianchi, E, Rogge, L
Publicado 2010

Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort

por Soubrier, M, Lukas, C, Sibilia, J, Fautrel, B, Roux, F, Gossec, L, Patternotte, S, Dougados, M
Publicado 2011

Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE)

por Dougados, M, Braun, J, Szanto, S, Combe, B, Elbaz, M, Geher, P, Thabut, G, Leblanc, V, Logeart, I
Publicado 2011

Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data

por Dougados, M, Schmidely, N, Le Bars, M, Lafosse, C, Schiff, M, Smolen, J S, Aletaha, D, van Riel, P, Wells, G
Publicado 2008

Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patien...

por Wells, G, Becker, J-C, Teng, J, Dougados, M, Schiff, M, Smolen, J, Aletaha, D, van Riel, P L C M
Publicado 2008

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthr...

por Schiff, M, Keiserman, M, Codding, C, Songcharoen, S, Berman, A, Nayiager, S, Saldate, C, Li, T, Aranda, R, Becker, J-C, Lin, C, Cornet, P L N, Dougados, M
Publicado 2008

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (th...

por Emery, P, Durez, P, Dougados, M, Legerton, C W, Becker, J-C, Vratsanos, G, Genant, H K, Peterfy, C, Mitra, P, Overfield, S, Qi, K, Westhovens, R
Publicado 2009

A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis

por Sieper, J., van der Heijde, D., Dougados, M., Maksymowych, W. P., Scott, B. B., Boice, J. A., Berd, Y., Bergman, G., Curtis, S., Tzontcheva, A., Huyck, S., Weng, H. H.
Publicado 2015

Effect of Certolizumab Pegol Over Ninety-Six Weeks in Patients With Axial Spondyloarthritis: Results from a Phase III Randomized Trial

por Sieper, J, Landewé, R, Rudwaleit, M, van der Heijde, D, Dougados, M, Mease, P J, Braun, J, Deodhar, A, Kivitz, A, Walsh, J, Hoepken, B, Nurminen, T, Maksymowych, W P
Publicado 2015

Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists

por Gossec, L, Dougados, M, Phillips, C, Hammoudeh, M, de Vlam, K, Pavelka, K, Pham, T, Braun, J, Sieper, J, Olivieri, I, van der Heijde, D, Collantes, E, Stone, M, Kvien, T K
Publicado 2008

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Ph...

por Landewé, R, Braun, J, Deodhar, A, Dougados, M, Maksymowych, W P, Mease, P J, Reveille, J D, Rudwaleit, M, van der Heijde, D, Stach, C, Hoepken, B, Fichtner, A, Coteur, G, de Longueville, M, Sieper, J
Publicado 2014

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry

por Salmon, J H, Cacoub, P, Combe, B, Sibilia, J, Pallot-Prades, B, Fain, O, Cantagrel, A, Dougados, M, Andres, E, Meyer, O, Carli, P, Pertuiset, E, Pane, I, Maurier, F, Ravaud, P, Mariette, X, Gottenberg, J E
Publicado 2015

Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target rec...

por Schoels, M M, Braun, J, Dougados, M, Emery, P, Fitzgerald, O, Kavanaugh, A, Kvien, T K, Landewé, R, Luger, T, Mease, P, Olivieri, I, Reveille, J, Ritchlin, C, Rudwaleit, M, Sieper, J, Smolen, J S, de Wit, M, van der Heijde, D
Publicado 2014

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and...

por Visser, K, Katchamart, W, Loza, E, Martinez-Lopez, J A, Salliot, C, Trudeau, J, Bombardier, C, Carmona, L, van der Heijde, D, Bijlsma, J W J, Boumpas, D T, Canhao, H, Edwards, C J, Hamuryudan, V, Kvien, T K, Leeb, B F, Martín-Mola, E M, Mielants, H, Müller-Ladner, U, Murphy, G, Østergaard, M, Pereira, I A, Ramos-Remus, C, Valentini, G, Zochling, J, Dougados, M
Publicado 2008

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

por Braun, J, van den Berg, R, Baraliakos, X, Boehm, H, Burgos-Vargas, R, Collantes-Estevez, E, Dagfinrud, H, Dijkmans, B, Dougados, M, Emery, P, Geher, P, Hammoudeh, M, Inman, RD, Jongkees, M, Khan, MA, Kiltz, U, Kvien, TK, Leirisalo-Repo, M, Maksymowych, WP, Olivieri, I, Pavelka, K, Sieper, J, Stanislawska-Biernat, E, Wendling, D, Özgocmen, S, van Drogen, C, van Royen, BJ, van der Heijde, D
Publicado 2011